Pier-Luigi Lollini Selected Research

Trabectedin

1/2022

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pier-Luigi Lollini Research Topics

Disease

75	Neoplasms (Cancer) 01/2024 - 03/2002
20	Carcinoma (Carcinomatosis) 10/2022 - 04/2003
18	Ewing Sarcoma (Sarcoma, Ewing) 01/2024 - 03/2002
16	Rhabdomyosarcoma 01/2022 - 07/2002
16	Carcinogenesis 04/2019 - 09/2002
14	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2007
12	Breast Neoplasms (Breast Cancer) 08/2023 - 06/2004
9	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 05/2005
8	Osteosarcoma (Osteogenic Sarcoma) 01/2024 - 05/2005
3	Hypoxia (Hypoxemia) 01/2021 - 01/2013
2	Hepatitis B 01/2018 - 10/2010
2	Communicable Diseases (Infectious Diseases) 06/2015 - 10/2010
1	Papillomavirus Infections 08/2023
1	Testicular Neoplasms (Testicular Cancer) 07/2023
1	Genetic Translocation (Chromosomal Translocation) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Disease Progression 09/2020
1	Noncommunicable Diseases 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Papilloma (Papillomatosis) 01/2018

Drug/Important Bio-Agent (IBA)

34	VaccinesIBA 08/2023 - 10/2002
12	AntigensIBA 01/2024 - 02/2003
12	AntibodiesIBA 10/2022 - 11/2004
11	Interleukin-12 (IL 12)IBA 01/2018 - 06/2003
11	Proteins (Proteins, Gene)FDA Link 02/2011 - 07/2002
9	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 05/2003
8	CytokinesIBA 12/2023 - 04/2003
8	Monoclonal AntibodiesIBA 10/2022 - 07/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 01/2006
5	Insulin-Like PeptidesIBA 04/2019 - 02/2010
5	DNA VaccinesIBA 01/2014 - 03/2005
4	Cancer VaccinesIBA 08/2023 - 11/2007
4	Biomarkers (Surrogate Marker)IBA 07/2023 - 09/2020
4	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 11/2004
4	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 06/2003
3	dactolisibIBA 01/2022 - 01/2010
3	EnzymesIBA 01/2021 - 12/2010
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2007
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 07/2002
3	ErbB Receptors (EGF Receptor)IBA 11/2016 - 07/2002
3	PerforinIBA 05/2015 - 04/2003
3	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 05/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2011 - 02/2003
3	Tamoxifen FDA LinkGeneric 12/2011 - 06/2003
3	Myosins (Myosin)IBA 04/2009 - 06/2003
3	Peptides (Polypeptides)IBA 03/2006 - 05/2003
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2005 - 03/2002
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2023 - 06/2005
2	CholesterolIBA 12/2022 - 12/2022
2	Trastuzumab (Herceptin)FDA Link 10/2022 - 08/2017
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2020
2	LigandsIBA 10/2020 - 08/2007
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2010
2	Phosphotransferases (Kinase)IBA 04/2019 - 05/2005
2	human ERBB2 proteinIBA 04/2019 - 01/2018
2	Neutralizing AntibodiesIBA 02/2019 - 03/2002
2	Caveolin 1IBA 01/2019 - 04/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 02/2014
2	CarcinogensIBA 01/2018 - 02/2005
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 01/2010
2	Interleukin-15 (Interleukin 15)IBA 05/2015 - 06/2004
2	InterleukinsIBA 11/2007 - 06/2004
2	Connective Tissue Growth FactorIBA 01/2007 - 03/2004
2	Growth Factor ReceptorsIBA 10/2005 - 07/2002
2	Small Interfering RNA (siRNA)IBA 06/2005 - 03/2004
1	Interleukin-1 (Interleukin 1)IBA 01/2024
1	PhosphatidylserinesIBA 12/2023
1	CalreticulinIBA 12/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	Subfamily A ATP Binding Cassette TransporterIBA 12/2022
1	Tyrosine Kinase InhibitorsIBA 11/2022
1	CrizotinibIBA 11/2022
1	Virus-Like Particle VaccinesIBA 10/2022
1	Lamin Type A (Lamin A)IBA 01/2022
1	EWS-FLI fusion proteinIBA 01/2022
1	TrabectedinIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	ZyxinIBA 01/2022
1	ClaudinsIBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Sunitinib (Sutent)FDA Link 11/2021
1	InflammasomesIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	InterferonsIBA 10/2020
1	Mitogen-Activated Protein KinasesIBA 10/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	MC3343IBA 01/2018
1	MethyltransferasesIBA 01/2018

Therapy/Procedure

21	Therapeutics 10/2022 - 07/2002
11	Immunotherapy 01/2024 - 02/2003
3	Drug Therapy (Chemotherapy) 09/2020 - 01/2013
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 02/2019